Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Revenue

In the year 2024, Burning Rock Biotech had annual revenue of 515.82M CNY, down -4.02%. Burning Rock Biotech had revenue of 126.02M in the quarter ending December 31, 2024, with 4.08% growth.

• Revenue (ttm): 515.82M CNY
• Revenue Growth: -4.02%
• P/S Ratio: 0.41
• Revenue / Employee: 656,262 CNY
• Employees: 786
• Market Cap: 28.72M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	515.82M	-21.61M	-4.02%
Dec 31, 2023	537.44M	-25.80M	-4.58%
Dec 31, 2022	563.24M	55.38M	10.90%
Dec 31, 2021	507.86M	77.96M	18.13%
Dec 31, 2020	429.90M	48.23M	12.64%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.